Cebpa Gene Leukemia Myeloid Acute Form Due To Cebpa Germline Mutation Ngs Genetic Dna Test
Introduction
The Cebpa Gene Leukemia Myeloid Acute Form Due To Cebpa Germline Mutation NGS Genetic DNA Test is a vital diagnostic tool for understanding the genetic predisposition to acute myeloid leukemia (AML). This test utilizes Next Generation Sequencing (NGS) technology to analyze mutations in the CEBPA gene, which are critical in the development of this aggressive form of cancer. Early detection through genetic testing can significantly impact treatment decisions and patient outcomes.
What the Test Measures
This test specifically detects mutations in the CEBPA gene, which can influence the behavior of leukemia in affected individuals. By identifying these mutations, healthcare providers can tailor treatment plans to the genetic profile of the patient, potentially improving prognosis.
Who Should Consider This Test
Individuals who may benefit from this test include:
- Patients diagnosed with acute myeloid leukemia (AML).
- Individuals with a family history of CEBPA mutations or leukemia.
- Patients experiencing symptoms such as unexplained fatigue, frequent infections, or easy bruising.
Benefits of Taking the Test
Taking the Cebpa Gene Leukemia Myeloid Acute Form Test offers several benefits:
- Identifies genetic mutations that may affect treatment options.
- Helps in understanding the risk of developing leukemia in family members.
- Guides oncologists in creating personalized treatment plans.
Understanding Your Results
Results from the Cebpa Gene Test will indicate whether or not CEBPA mutations are present. A positive result may suggest a higher risk for leukemia, while a negative result can provide reassurance. It is essential to discuss results with a healthcare provider for proper interpretation and guidance on next steps.
Test Name and Price
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Cebpa Gene Leukemia Myeloid Acute Form NGS Genetic DNA Test | 40,000 KSh | 56,000 KSh |
Branches and Booking
We have branches across Kenya, including Nairobi, Mombasa, and Kisumu, and offer a convenient home sample collection service. To book the Cebpa Gene Leukemia Myeloid Acute Form Test, please call or WhatsApp us at +254713408028. Take the first step towards understanding your health today!
Turnaround time for results is approximately 3 to 4 weeks. Sample types accepted include blood, extracted DNA, or one drop of blood on an FTA card. Prior to testing, a clinical history review and genetic counseling session are recommended to assess family history related to CEBPA mutations.
